DAWN
Price
$10.63
Change
-$0.53 (-4.75%)
Updated
Feb 4, 02:35 PM (EDT)
Capitalization
1.14B
33 days until earnings call
Intraday BUY SELL Signals
MNKD
Price
$5.86
Change
-$0.35 (-5.64%)
Updated
Feb 4, 03:03 PM (EDT)
Capitalization
1.91B
27 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

DAWN vs MNKD

Header iconDAWN vs MNKD Comparison
Open Charts DAWN vs MNKDBanner chart's image
Day One Biopharmaceuticals
Price$10.63
Change-$0.53 (-4.75%)
Volume$2.18K
Capitalization1.14B
MannKind
Price$5.86
Change-$0.35 (-5.64%)
Volume$5.88K
Capitalization1.91B
DAWN vs MNKD Comparison Chart in %
DAWN
Daily Signal:
Gain/Loss:
MNKD
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
DAWN vs. MNKD commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DAWN is a Hold and MNKD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (DAWN: $11.16 vs. MNKD: $6.21)
Brand notoriety: DAWN and MNKD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DAWN: 68% vs. MNKD: 116%
Market capitalization -- DAWN: $1.14B vs. MNKD: $1.91B
DAWN [@Biotechnology] is valued at $1.14B. MNKD’s [@Biotechnology] market capitalization is $1.91B. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DAWN’s FA Score shows that 0 FA rating(s) are green whileMNKD’s FA Score has 0 green FA rating(s).

  • DAWN’s FA Score: 0 green, 5 red.
  • MNKD’s FA Score: 0 green, 5 red.
According to our system of comparison, DAWN is a better buy in the long-term than MNKD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DAWN’s TA Score shows that 3 TA indicator(s) are bullish while MNKD’s TA Score has 7 bullish TA indicator(s).

  • DAWN’s TA Score: 3 bullish, 6 bearish.
  • MNKD’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, MNKD is a better buy in the short-term than DAWN.

Price Growth

DAWN (@Biotechnology) experienced а -9.49% price change this week, while MNKD (@Biotechnology) price change was +11.09% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.39%. For the same industry, the average monthly price growth was +1.48%, and the average quarterly price growth was +33.05%.

Reported Earning Dates

DAWN is expected to report earnings on Mar 09, 2026.

MNKD is expected to report earnings on Mar 03, 2026.

Industries' Descriptions

@Biotechnology (-2.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MNKD($1.91B) has a higher market cap than DAWN($1.15B). DAWN YTD gains are higher at: 19.742 vs. MNKD (9.524). MNKD has higher annual earnings (EBITDA): 73.2M vs. DAWN (-162.07M). DAWN has more cash in the bank: 452M vs. MNKD (260M). DAWN has less debt than MNKD: DAWN (2.89M) vs MNKD (120M). MNKD has higher revenues than DAWN: MNKD (314M) vs DAWN (134M).
DAWNMNKDDAWN / MNKD
Capitalization1.15B1.91B60%
EBITDA-162.07M73.2M-221%
Gain YTD19.7429.524207%
P/E RatioN/A62.20-
Revenue134M314M43%
Total Cash452M260M174%
Total Debt2.89M120M2%
FUNDAMENTALS RATINGS
MNKD: Fundamental Ratings
MNKD
OUTLOOK RATING
1..100
18
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
PROFIT vs RISK RATING
1..100
59
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
63
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DAWNMNKD
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
76%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
77%
Momentum
ODDS (%)
Bearish Trend 2 days ago
73%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
75%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 9 days ago
80%
Bullish Trend 2 days ago
80%
Declines
ODDS (%)
Bearish Trend 7 days ago
80%
Bearish Trend 20 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
Aroon
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 6 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
DAWN
Daily Signal:
Gain/Loss:
MNKD
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IRFAX9.500.10
+1.06%
Cohen & Steers International Realty A
TSRMX18.130.07
+0.39%
Touchstone Sands Cptl Emerg Mkts Gr R6
FBSIX39.050.01
+0.03%
Franklin Mutual U.S. Mid Cap Value R6
FFIDX114.07N/A
N/A
Fidelity
WCPIX59.33-1.47
-2.42%
Communication Services UltraSectorProInv

DAWN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DAWN has been loosely correlated with OCUL. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if DAWN jumps, then OCUL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DAWN
1D Price
Change %
DAWN100%
-2.96%
OCUL - DAWN
48%
Loosely correlated
-6.99%
IMTX - DAWN
46%
Loosely correlated
-0.40%
NUVL - DAWN
45%
Loosely correlated
+2.12%
BEAM - DAWN
44%
Loosely correlated
-0.11%
ERAS - DAWN
44%
Loosely correlated
-0.24%
More

MNKD and

Correlation & Price change

A.I.dvisor indicates that over the last year, MNKD has been loosely correlated with IONS. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if MNKD jumps, then IONS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MNKD
1D Price
Change %
MNKD100%
+3.33%
IONS - MNKD
50%
Loosely correlated
+1.83%
VCYT - MNKD
44%
Loosely correlated
-1.10%
CYTK - MNKD
43%
Loosely correlated
-0.66%
INSM - MNKD
40%
Loosely correlated
+2.07%
DAWN - MNKD
39%
Loosely correlated
-2.96%
More